Partner Gregory Sichenzia Quoted on the Impact of Market Volatility on Biotech Issuers
January 19, 2016 – Partner Greg Sichenzia, whose clients include Swedish and Israeli biotech companies, was quoted in a Law360 article titled “Market Volatility Cools Attys’ Hopes For ‘JPMorgan Bounce’.” The article discussed that lawyers and deal makers at JPMorgan’s annual health care conference held in San Francisco last week hoped the gathering would reignite public offerings in the biotech sector, but some ended the week concerned that macroeconomic instability will keep capital markets activity suppressed.
Read the full article here.
- Sichenzia Ross Ference LLP Team Featured in China Business Law Journal - March 29, 2023
- Sichenzia Ross Ference LLP Represents Spartan Capital Securities, LLC in a $1.25 Million U.S. Private Placement of Alpha Cognition, Inc. - March 16, 2023
- Sichenzia Ross Ference LLP Represents EzFill Holdings, Inc., in $2,096,000 At-The-Market Offering Facility - March 3, 2023